Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials

Authors: Gallois, Claire, Sroussi, Marine, André, Thierry, Mouillet-Richard, Sophie, Agueeff, Natacha, Mulot, Claire, Vernerey, Dewi, Louvet, Christophe, Bachet, Jean-Baptiste, Dourthe, Louis-Marie, Mazard, Thibault, Jary, Marine, Coutzac, Clélia, Lecaille, Cédric, Tabernero, Josep, van Laethem, Jean-Luc, Lepage, Côme, Emile, Jean-François, de Reyniès, Aurélien, Taieb, Julien, Laurent-Puig, Pierre

Contributors: Institut Català de la Salut, [Gallois C] Centre de Recherche des Cordeliers, INSERM, Université Paris Cité, Sorbonne Université, Paris, France. Digestive Oncology Department, Institut du Cancer Paris CARPEM, APHP, APHP Centre, Hopital Européen G. Pompidou, Université Paris Cité, Paris, France. [Sroussi M] Centre de Recherche des Cordeliers, INSERM, Université Paris Cité, Sorbonne Université, Paris, France. Institut Chimie Biologie Innovation—Laboratoire de BioChimie, ESPCI, UMR8231 CNRS, Université PSL, Paris, France. [André T] Department of Medical Oncology, Hôpital Saint Antoine, Sorbonne Université, Paris, France. [Mouillet-Richard S, Agueeff N, Mulot C] Centre de Recherche des Cordeliers, INSERM, Université Paris Cité, Sorbonne Université, Paris, France. [Tabernero J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOBQuiron, UVic-UCC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Laurent-Puig, Pierre, Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École Pratique des Hautes Études (EPHE), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Cancer Research and Personalized Medicine - CARPEM Paris (SIRIC CARPEM), Hôpital Européen Georges Pompidou APHP (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpital Cochin AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Necker - Enfants Malades AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut national du cancer (INCa)-Université Paris Cité (UPCité), Centre de ressources historiques de l'ESPCI (ESPCI-CRH), Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL), Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098) (RIGHT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang Bourgogne-Franche-Comté (EFS BFC)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté COMUE (UBFC)-Université Bourgogne Franche-Comté COMUE (UBFC), Institut Mutualiste de Montsouris (IMM), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Laboratoire de Biologie Médicale SeqOIA Paris (seqOIA)

Source: J Clin Oncol
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: Male, DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms::Colonic Neoplasms, Other subheadings::Other subheadings::Other subheadings::/genetics, FENÓMENOS Y PROCESOS::fenómenos genéticos::expresión génica::transcripción genética::fenómenos genéticos::transcriptoma, [SDV]Life Sciences [q-bio], Còlon - Càncer - Aspectes genètics, Biocartis, Transcriptomes, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales::neoplasias del colon, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, Otros calificadores::Otros calificadores::Otros calificadores::/genética, Tumor Microenvironment, Biomarkers, Tumor, Humans, Roche, Neoplasm Staging, Aged, Royalties, Expenses: Roche, Other Intellectual Property: Inventor of mir31-3p license to IntegraGen Travel, Merck, Gene Expression Profiling, Cell Cycle, AstraZeneca, PHENOMENA AND PROCESSES::Genetic Phenomena::Gene Expression::Transcription, Genetic::Genetic Phenomena::Transcriptome, ORIGINAL REPORTS, Bristol Myers Squibb, Middle Aged, Prognosis, Amgen, Boehringer Ingelheim Patents, [SDV] Life Sciences [q-bio], Còlon - Càncer - Prognosi, Accommodations, Còlon - Càncer - Recaiguda, MSD Oncology Consulting or Advisory Role: Merck, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Colonic Neoplasms, Female, France, Neoplasm Recurrence, Local, Transcriptome, Sanofi

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39889251
http://hdl.handle.net/11351/13348
https://hal.science/hal-04955616v1
https://hal.science/hal-04955616v1/document
https://doi.org/10.1200/jco.23.02262

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study

Authors: Shailender Bhatia, Suzanne L. Topalian, William Sharfman, Tim Meyer, Neil Steven, Christopher D. Lao, Lorena Fariñas-Madrid, Lot A. Devriese, Kathleen Moore, Robert L. Ferris, Yoshitaka Honma, Ileana Elias, Anjaiah Srirangam, Charlie Garnett-Benson, Michelle Lee, Paul Nghiem

Contributors: Institut Català de la Salut, [Bhatia S] Division of Hematology-Oncology, University of Washington and Fred Hutchinson Cancer Center, Seattle, WA. [Topalian SL, Sharfman W] Division of Hematology-Oncology, University of Washington and Fred Hutchinson Cancer Center, Seattle, WA. Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. [Meyer T] Department of Oncology, University College London Cancer Institute, London, United Kingdom. [Steven N] Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. [Lao CD] Michigan Medicine, Rogel Cancer Center, Ann Arbor, MI. [Fariñas-Madrid L] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, MS Medische Oncologie, Cancer

Source: J Clin Oncol
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: Male, Adult, Cancer Research, Skin Neoplasms, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome::Progression-Free Survival, Quimioteràpia combinada, Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica, Medicaments antineoplàstics - Ús terapèutic - Efectes secundaris, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, Journal Article, Humans, Pell - Càncer - Recaiguda, Immune Checkpoint Inhibitors, ENFERMEDADES::virosis::infecciones por virus ADN::infecciones por Polyomavirus::carcinoma de células de Merkel, Aged, Aged, 80 and over, Other subheadings::Other subheadings::Other subheadings::/drug therapy, ORIGINAL REPORTS, Middle Aged, Ipilimumab, Progression-Free Survival, Carcinoma, Merkel Cell, Pell - Càncer - Tractament, Nivolumab, Oncology, Other subheadings::Other subheadings::Other subheadings::/adverse effects, DISEASES::Virus Diseases::DNA Virus Infections::Polyomavirus Infections::Carcinoma, Merkel Cell, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Anticossos monoclonals - Ús terapèutic - Efectes secundaris, Avaluació de resultats (Assistència sanitària), ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias cutáneas, Female, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento::supervivencia libre de progresión, DISEASES::Neoplasms::Neoplasms by Site::Skin Neoplasms, Neoplasm Recurrence, Local

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39889250
http://hdl.handle.net/11351/12809
https://dspace.library.uu.nl/handle/1874/460578

Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial

Authors: Robert J. Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli, Carlos Rojas, Marine Gross-Goupil, Giovanni Schinzari, Bohuslav Melichar, Philippe Barthélémy, Abraham Ruiz Garcia, Jeffrey Sosman, Marc-Oliver Grimm, Jeffrey C. Goh, Cristina Suarez, Christian K. Kollmannsberger, Suresh G. Nair, Brian M. Shuch, Jian Huang, Burcin Simsek, Julia Spiridigliozzi, Chung-Wei Lee, Maximiliano van Kooten Losio, Viktor Grünwald

Contributors: Institut Català de la Salut, [Motzer RJ] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. [Bex A] Netherlands Cancer Institute, Amsterdam, the Netherlands. University College London, London, United Kingdom. [Russo P] Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. [Tomita Y] Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. [Cutuli HJ] Hospital Sirio Libanés, Buenos Aires, Argentina. [Rojas C] Bradford Hill, Santiago, Chile. [Suarez C] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: J Clin Oncol
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: Male, Adult, Ronyons - Càncer - Recaiguda, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Medizin, Nephrectomy, Quimioteràpia combinada, Disease-Free Survival, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias renales, Double-Blind Method, ENFERMEDADES::neoplasias::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias renales::carcinoma de células renales, Medicaments antineoplàstics - Ús terapèutic - Efectes secundaris, Antineoplastic Combined Chemotherapy Protocols, DISEASES::Chemically-Induced Disorders::Drug-Related Side Effects and Adverse Reactions, Humans, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Urogenital Surgical Procedures::Urologic Surgical Procedures::Nephrectomy, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Kidney Neoplasms, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento combinado::quimioterapia adyuvante, Carcinoma, Renal Cell, Aged, Aged, 80 and over, Other subheadings::Other subheadings::Other subheadings::/drug therapy, Ronyons - Càncer - Cirurgia, ENFERMEDADES::trastornos inducidos químicamente::efectos colaterales y reacciones adversas relacionados con medicamentos, DISEASES::Neoplasms::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Kidney Neoplasms::Carcinoma, Renal Cell, ORIGINAL REPORTS, Middle Aged, Ipilimumab, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Combined Modality Therapy::Chemotherapy, Adjuvant, Kidney Neoplasms, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::procedimientos quirúrgicos urogenitales::procedimientos quirúrgicos urológicos::nefrectomía, Nivolumab, Chemotherapy, Adjuvant, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Ronyons - Càncer - Tractament, Female, Neoplasm Recurrence, Local

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39303200
http://hdl.handle.net/11351/12750

PATH classification: a proposal for patients with HNSCC treated with salvage surgery

Authors: Albert Llansana, David Virós Porcuna, Rosselin Vasquez, Arnau Parellada, Cristina Valero, Anna Holgado, Xavier León

Contributors: Institut Català de la Salut, [Llansana A] Otorhinolaryngology Department, Hospital Mutua de Terrassa, Terrassa, Spain. [Virós Porcuna D] Servei d’Otorrinolaringologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Vasquez R, Parellada A, Valero C, Holgado A] Otorhinolaryngology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Eur Arch Otorhinolaryngol
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: Male, Adult, ENFERMEDADES::neoplasias::neoplasias::neoplasias por localización::neoplasias de cabeza y cuello::carcinoma de células escamosas de cabeza y cuello, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento de última línea, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Neoplasm Staging, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::estadificación de neoplasias, Metàstasi limfàtica, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Salvage Therapy, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Metastasis::Lymphatic Metastasis, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, Càncer - Recaiguda, DISEASES::Neoplasms::Neoplasms::Neoplasms by Site::Head and Neck Neoplasms::Squamous Cell Carcinoma of Head and Neck, Coll - Càncer - Cirurgia, Humans, Other subheadings::Other subheadings::Other subheadings::/surgery, Retrospective Studies, Aged, Neoplasm Staging, Salvage Therapy, Aged, 80 and over, Otros calificadores::Otros calificadores::Otros calificadores::/cirugía, ENFERMEDADES::neoplasias::procesos neoplásicos::metástasis neoplásica::metástasis linfática, Squamous Cell Carcinoma of Head and Neck, Margins of Excision, Cap - Càncer - Cirurgia, Middle Aged, Prognosis, Coll - Càncer - Prognosi, Head and Neck Neoplasms, Lymphatic Metastasis, Cap - Càncer - Prognosi, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Carcinoma, Squamous Cell, Female, Neoplasm Recurrence, Local, Head and Neck

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39312000
http://hdl.handle.net/11351/12704

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])

Authors: A. DeMichele, A. C. Dueck, D. Hlauschek, M. Martin, H. Burstein, G. Pfeiler, N. Zdenkowski, A. Wolff, M. Bellet-Ezquerra, E. Winer, M. Balic, K. Miller, M. Colleoni, D. Lake, G. Rubovsky, D. Cameron, J. Balko, C. F. Singer, Z. Nowecki, H. Iwata, N. Wolmark, K. A. Parraga, H. Rugo, G. G. Steger, T. Traina, G. Werutsky, D. Czajkowska, O. Metzger, S. El-Abed, K. P. Theall, R. D. Lu, P. O’Brien, C. Fesl, E. Mayer, M. Gnant

Contributors: Institut Català de la Salut, [DeMichele A] Department of Hematology and Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, USA. ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA. [Dueck AC] Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Phoenix, AZ, USA. [Hlauschek D] Austrian Breast & Colorectal Cancer Study Group (ABCSG), Vienna, Austria. [Martin M] Gregorio Maranon, Madrid, Spain. [Burstein H] Dana-Farber Cancer Institute, Boston, MA, USA. Alliance Foundation Trials (AFT) LLC, Boston, MA, USA. [Pfeiler G] Medical University of Vienna, Vienna, Austria. [Bellet Ezquerra M] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Breast Cancer Res
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Breast Cancer Research, Vol 27, Iss 1, Pp 1-8 (2025)

Subject Terms: Adult, Mama - Càncer - Prognosi, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada, Pyridines, Receptor, ErbB-2, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Neoplasm Staging, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::estadificación de neoplasias, Mama - Càncer - Recaiguda, Breast Neoplasms, CDK4/6 inhibitor, Quimioteràpia combinada, Piperazines, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, Antineoplastic Combined Chemotherapy Protocols, Humans, Stage II breast cancer, Adjuvant, RC254-282, Neoplasm Staging, Aged, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento, Treatment Outcome, Chemotherapy, Adjuvant, Mama - Càncer - Tractament, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Avaluació de resultats (Assistència sanitària), Female, Neoplasm Recurrence, Local, Endocrine, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39849600
http://hdl.handle.net/11351/12772
https://doaj.org/article/054e50e8fd924275b24a583124a5d13f

Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer

Authors: Klara Hammarström, Luís Nunes, Lucy Mathot, Artur Mezheyeuski, Emma Lundin, Nafsika Korsavidou Hult, Israa Imam, Emerik Osterlund, Tobias Sjöblom, Bengt Glimelius

Contributors: Institut Català de la Salut, [Hammarström K, Nunes L, Mathot L, Lundin E] Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. [Mezheyeuski A] Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Korsavidou Hult N] Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden, Vall d'Hebron Barcelona Hospital Campus

Source: Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: Male, Adult, 0301 basic medicine, complete remission, Nerve Tissue Proteins, chemoradiotherapy, Recte - Càncer - Quimioteràpia, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Combined Modality Therapy::Neoadjuvant Therapy, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales::neoplasias del recto, 0302 clinical medicine, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento combinado::tratamiento neoadyuvante, Biomarkers, Tumor, Humans, Rectal cancer, targeted sequencing, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento combinado::quimiorradioterapia, radiotherapy, Aged, Smad4 Protein, Aged, 80 and over, Cancer och onkologi, FENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutación, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Combined Modality Therapy::Chemoradiotherapy, Rectal Neoplasms, DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms::Rectal Neoplasms, Nuclear Proteins, Chemoradiotherapy, Middle Aged, Recte - Càncer - Radioteràpia, Neoadjuvant Therapy, Cytoskeletal Proteins, Anomalies cromosòmiques, Treatment Outcome, Cancer and Oncology, PHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::Mutation, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Mutation, response pre-diction, Recte - Càncer - Recaiguda, Female, prognosis, Neoplasm Recurrence, Local

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38376070
https://hdl.handle.net/11351/11484
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-493842
https://publications.scilifelab.se/publication/60d83cc8c444462f8cfce90048ed5781

Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real‐world setting

Authors: Adrián Alegre, Mercedes Gironella, Fernando Escalante, Juan M. Bergua, Carmen Martínez‐Chamorro, Aurelio López, Esther González, Abelardo Bárez, Nieves Somolinos, Ernesto P. Persona, Alexia S. Cabrera, Alfons Soler, Belén I. Rodríguez, Joaquín M. López, Yolanda González, Verónica C. Giménez, Antonia Sampol, Carolina Muñoz, David Vilanova, Marta Durán, Carlos Fernández de Larrea, Spanish Myeloma Group (GEM_PETHEMA)

Contributors: Institut Català de la Salut, [Alegre A] Hospital Universitario de la Princesa, Madrid, Spain. [Gironella M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Escalante F] Hospital Universitario de León, León, Spain. [Bergua JM] Hospital San Pedro de Alcántara Cáceres, Spain. [Martínez‐Chamorro C] Hospital Universitario Quirónsalud Madrid, Spain. [López A] Hospital Universitari Arnau de Vilanova, Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Hemasphere
Docusalut
Conselleria de Salut i Consum del Govern de les Illes Balears
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
HemaSphere, Vol 8, Iss 7, Pp n/a-n/a (2024)

Subject Terms: Mieloma múltiple - Tractament, Other subheadings::Other subheadings::Other subheadings::/drug therapy, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Mieloma múltiple - Recaiguda, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome::Progression-Free Survival, Articles, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de células plasmáticas::mieloma múltiple, 3. Good health, 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, 0302 clinical medicine, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Plasma Cell::Multiple Myeloma, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Avaluació de resultats (Assistència sanitària), Diseases of the blood and blood-forming organs, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento::supervivencia libre de progresión, RC633-647.5

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38974896
https://hdl.handle.net/20.500.13003/20654
https://fisabio.portalinvestigacion.com/publicaciones/17506
https://hdl.handle.net/11351/11702
https://doaj.org/article/93a4ae9108d049fa97aadb08fd5697cd

Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma—A Multicentre Propensity Score Matching Analysis of the Recurrence After Whipple’s (RAW) Study

Authors: Bellotti, Ruben, Aroori, Somaiah, Cardini, Benno, Ponholzer, Florian, Russell, Thomas B., Labib, Peter L., Schneeberger, Stefan, Ausania, Fabio, Pando, Elizabeth, Roberts, Keith J., Kausar, Ambareen, Mavroeidis, Vasileios K., Marangoni, Gabriele, Thomasset, Sarah C., Frampton, Adam E., Lykoudis, Pavlos, Alhaboob, Nassir, Bari, Hassaan, Smith, Andrew M., Spalding, Duncan, Srinivasan, Parthi, Davidson, Brian R., Bhogal, Ricky H., Croagh, Daniel, Dominguez, Ismael, Thakkar, Rohan, Gomez, Dhanny, Silva, Michael A., Lapolla, Pierfrancesco, Mingoli, Andrea, Porcu, Alberto, Shah, Nehal S., Hamady, Zaed Z. R., Al-Sarrieh, Bilal, Serrablo, Alejandro, RAW Study Collaborators, Perra, Teresa, Maglione, Manuel

Contributors: Institut Català de la Salut, [Bellotti R, Cardini B, Ponholzer F] Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria. [Aroori S, Russell TB, Labib PL] Department of HPB Surgery, University Hospitals Plymouth NHS Trust, Plymouth, UK. [Pando E] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Cancers (Basel)
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: Otros calificadores::Otros calificadores::Otros calificadores::/cirugía, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas, Pàncrees - Càncer - Recaiguda, Pàncrees - Càncer - Cirurgia, DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms, Article, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, Pàncrees - Càncer - Tractament, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, ENFERMEDADES::neoplasias::neoplasias::neoplasias::neoplasias por localización::neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias pancreáticas::carcinoma ductal pancreático, DISEASES::Neoplasms::Neoplasms::Neoplasms::Neoplasms by Site::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Pancreatic Neoplasms::Carcinoma, Pancreatic Ductal, Other subheadings::Other subheadings::Other subheadings::/surgery, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Digestive System Surgical Procedures::Pancreaticoduodenectomy, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::procedimientos quirúrgicos del sistema digestivo::pancreatoduodenectomía

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/40227808
http://hdl.handle.net/11351/13148
https://hdl.handle.net/11388/361211
https://doi.org/10.3390/cancers17071223

Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application

Authors: Carlos Casas-Arozamena, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Eva Diaz, Sara S Oltra, Cristian Pablo Moiola, Silvia Cabrera, Alexandra Cortegoso, Teresa Curiel, Alicia Abalo, Mónica Pamies Serrano, Santiago Domingo del Pozo, Pablo Padilla-Iserte, Marta Arnaez de la Cruz, Alicia Hernández, Virginia García-Pineda, Juan Ruiz Bañobre, Rafael López, Xavier Matias-Guiu, Eva Colás, Antonio Gil-Moreno, Miguel Abal, Gema Moreno-Bueno, Laura Muinelo-Romay

Contributors: Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación (España), Agencia Estatal de Investigación (España), Fundación Científica Asociación Española Contra el Cáncer, European Commission, Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72], Institut Català de la Salut, [Casas-Arozamena C] Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain. University of Santiago de Compostela (USC), Santiago de Compostela, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. [Vilar A, Arias E, Sampayo V] Department of Gynecology, University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain. [Cueva J] Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain. Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain. [Diaz E] MD Anderson Cancer Center Foundation, Madrid, Spain. [Moiola CP] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Department of Basic Sciences, Faculty of Health Sciences at Manresa, University of Vic – Central University of Catalonia (UVic-UCC), Manresa, Spain. [Cabrera S, Pamies Serrano M] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Colás E, Gil-Moreno A] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: J Exp Clin Cancer Res
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Dipòsit Digital de la UB
instname
Digital.CSIC. Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Repositori Obert UdL
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-14 (2024)

Subject Terms: Adult, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias endometriales, Other subheadings::Other subheadings::Other subheadings::/genetics, CHEMICALS AND DRUGS::Biological Factors::Biomarkers::Biomarkers, Tumor, COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores::marcadores tumorales, Biopsy, ADN, Risk Assessment, Blood biomarkers, Circulating Tumor DNA, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, Endometrial cancer, Endometri - Càncer - Recaiguda, Otros calificadores::Otros calificadores::Otros calificadores::/genética, Biomarkers, Tumor, COMPUESTOS QUÍMICOS Y DROGAS::nucleótidos y nucleósidos de ácidos nucleicos::ácidos nucleicos::ácidos nucleicos libres de células::ADN tumoral circulante, Humans, RC254-282, Aged, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Endometrial Neoplasms, Aged, 80 and over, Research, Marcadors tumorals, Biochemical markers, Liquid Biopsy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Prognosis, CHEMICALS AND DRUGS::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::Cell-Free Nucleic Acids::Circulating Tumor DNA, Endometrial Neoplasms, Prognostic biomarkers, Càncer d'endometri, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Marcadors bioquímics, Female, Tumour kinetics, Neoplasm Recurrence, Local, Biòpsia, Cell-Free Nucleic Acids, Endometri - Càncer - Aspectes genètics, Follow-Up Studies

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39304963
https://hdl.handle.net/2445/216601
http://hdl.handle.net/10261/371504
https://hdl.handle.net/11351/12160
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=21973
https://doaj.org/article/d684ea05bd3b4749890be7772b452478

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies

Authors: Pablo Berlanga, Gaelle Pierron, Ludovic Lacroix, Mathieu Chicard, Tiphaine Adam de Beaumais, Antonin Marchais, Anne C. Harttrampf, Yasmine Iddir, Alicia Larive, Aroa Soriano Fernandez, Imene Hezam, Cecile Chevassus, Virginie Bernard, Sophie Cotteret, Jean-Yves Scoazec, Arnaud Gauthier, Samuel Abbou, Nadege Corradini, Nicolas André, Isabelle Aerts, Estelle Thebaud, Michela Casanova, Cormac Owens, Raquel Hladun-Alvaro, Stefan Michiels, Olivier Delattre, Gilles Vassal, Gudrun Schleiermacher, Birgit Geoerger

Contributors: Institut Català de la Salut, [Berlanga P] Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. [Pierron G] Unité de Génétique Somatique, Service de Génétique, Hospital Group, Institut Curie, Paris, France. [Lacroix L] Department of Pathology and Laboratory Medicine, Translational Research Laboratory and Biobank, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. [Chicard M] INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Research Center, PSL Research University, Institut Curie, Paris, France. [Adam de Beaumais T] Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. [Marchais A] INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. [Soriano Fernandez A] Grup de Recerca Translacional en Càncer en la Infància i l’Adolescència, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Hladun-Alvaro R] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Oncologia i Hematologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, collette, yves, Institut Gustave Roussy (IGR), Département de cancérologie de l'enfant et de l'adolescent Gustave Roussy, Institut Curie Paris, Department of Medical Oncology, Département de médecine oncologique Gustave Roussy, Unité de génétique et biologie des cancers (U830), Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM), Plateforme de Bioinformatique Gustave Roussy, Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse (AMMICa), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Immunologie anti-tumorale et immunothérapie des cancers (ITIC), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition CHU Pitié Salpêtrière (IHU ICAN), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique Gustave Roussy, Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Centre de Recherche et de Documentation sur l'Océanie (CREDO), École des hautes études en sciences sociales (EHESS)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique Châtenay-Malabry (LabEx LERMIT), Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de biologie et pathologie médicales Gustave Roussy, Centre Hospitalier Lyon Sud CHU - HCL (CHLS), Hospices Civils de Lyon (HCL), Prédicteurs moléculaires et nouvelles cibles en oncologie (PMNCO), Centre Léon Bérard Lyon, Institut d'hématologie et d'oncologie pédiatrique CHU - HCL (IHOPe), Biologie Cellulaire et Cancer, Institut Curie Paris -Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo (IRCCS), Oncostat (U1018 (Équipe 2)), Institut Gustave Roussy (IGR)-Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Immunologie des tumeurs et immunothérapie (UMR 1015), Vectorologie et thérapeutiques anti-cancéreuses Villejuif (UMR 8203), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Centre National de la Recherche Scientifique (CNRS)

Source: Cancer Discov
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: Adolescent, [SDV]Life Sciences [q-bio], TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::medicina de precisión, DISEASES::Neoplasms, 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, 0302 clinical medicine, Càncer - Recaiguda, Biomarkers, Tumor, Humans, Medicina personalitzada, Prospective Studies, Precision Medicine, Child, Research Articles, Pediatria, Carcinoma, High-Throughput Nucleotide Sequencing, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Precision Medicine, 3. Good health, [SDV] Life Sciences [q-bio], ENFERMEDADES::neoplasias, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Mutation, Neoplasm Recurrence, Local, Cell-Free Nucleic Acids

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/35292802
https://hdl.handle.net/11351/8044
https://amu.hal.science/hal-04085309v1/document
https://amu.hal.science/hal-04085309v1
https://doi.org/10.1158/2159-8290.cd-21-1136

Radical Extirpation With Intraoperative Radiotherapy for Locally Recurrent Gynecologic Cancer: An Institutional Review

Authors: Ritchie Delara, Jie Yang, Elena Suárez-Salvador, Sujay Vora, Javier Magriña, Kristina Butler, Paul Magtibay

Contributors: Institut Català de la Salut, [Delara R, Yang J, Magriña J, Butler K] Department of Obstetrics and Gynecology, Mayo Clinic, Phoenix, AZ. [Suárez-Salvador E] Department of Obstetrics and Gynecology, Mayo Clinic, Phoenix, AZ. Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Vora S] Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, Vall d'Hebron Barcelona Hospital Campus

Source: Mayo Clin Proc Innov Qual Outcomes
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 6, Pp 1081-1088 (2021)

Subject Terms: Medicine (General), ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos, Otros calificadores::Otros calificadores::Otros calificadores::/cirugía, Otros calificadores::Otros calificadores::Otros calificadores::/radioterapia, Extirpació (Cirurgia), 3. Good health, 03 medical and health sciences, R5-920, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, 0302 clinical medicine, Aparell genital femení - Càncer - Cirurgia, Aparell genital femení - Càncer - Radioteràpia, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female, Original Article, Other subheadings::Other subheadings::Other subheadings::/surgery, Other subheadings::Other subheadings::Other subheadings::/radiotherapy

File Description: application/pdf

Access URL: http://www.mcpiqojournal.org/article/S2542454821001569/pdf
https://pubmed.ncbi.nlm.nih.gov/34841199
https://hdl.handle.net/11351/7594
https://doaj.org/article/5b0d6940b98b49b48699cc92f4854869
https://www.mcpiqojournal.org/article/S2542-4548(21)00156-9/fulltext
https://europepmc.org/article/PMC/PMC8606340
https://www.sciencedirect.com/science/article/pii/S2542454821001569

Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer

Authors: Daan G. Knapen, Sara Hone Lopez, Derk Jan A. de Groot, Jacco-Juri de Haan, Elisabeth G. E. de Vries, Rodrigo Dienstmann, Steven de Jong, Arkajyoti Bhattacharya, Rudolf S. N. Fehrmann

Contributors: Institut Català de la Salut, [Knapen DG, Hone Lopez S, de Groot DJA, de Haan JJ, de Vries EGE] Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. [Dienstmann R] Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Commun Med (Lond)
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Communications Medicine, Vol 4, Iss 1, Pp 1-10 (2024)

Subject Terms: 0301 basic medicine, 0303 health sciences, DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms, Other subheadings::Other subheadings::/therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Genetic Techniques::Gene Expression Profiling, Expressió gènica, Article, 3. Good health, Còlon - Càncer - Tractament, 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, Otros calificadores::Otros calificadores::/terapia, Càncer - Recaiguda, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales, Recte - Càncer - Tractament, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Medicine, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::técnicas genéticas::perfiles de expresión génica

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38702451
https://hdl.handle.net/11351/11444
https://doaj.org/article/8d7f690e987c46dca2d0be26c8c98c2b

Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma

Authors: Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Leary, Robert W. Holloway, Margarita Amenedo Gancedo, Peter C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Susana Banerjee, Jesus García-Donas, Elizabeth M. Swisher, David Cella, Juliette Meunier, Sandra Goble, Terri Cameron, Lara Maloney, Ann-Christin Mörk, Josh Bedel, Jonathan A. Ledermann, Robert L. Coleman

Contributors: Institut Català de la Salut, [Oza AM] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. [Lorusso D] Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. [Aghajanian C] Memorial Sloan Kettering Cancer Center, New York, NY. [Oaknin A] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Dean A] St John of God Subiaco Hospital, Subiaco, WA, Australia. [Colombo N] University of Milan-Bicocca and European Institute of Oncology, Milan, Italy, Vall d'Hebron Barcelona Hospital Campus

Source: J Clin Oncol
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname

Subject Terms: Cancer Research, Indoles, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::carcinoma epitelial de ovario, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Medicaments antineoplàstics - Ús terapèutic, Carcinoma, Ovarian Epithelial, Poly(ADP-ribose) Polymerase Inhibitors, 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, 0302 clinical medicine, Double-Blind Method, ARIEL3, Patient-Centered Care, RAPID COMMUNICATIONS, Humans, Multicenter Studies as Topic, 1306 Cancer Research, Rucaparib, Aged, Randomized Controlled Trials as Topic, Ovarian Neoplasms, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Carcinoma, Ovarian Epithelial, Other subheadings::Other subheadings::Other subheadings::/drug therapy, Patient-Centered Outcomes, Placebo-Controlled Trial, Rucaparib Maintenance Treatment, Patients With Recurrent Ovarian Carcinoma, Middle Aged, Ovarian Carcinoma, Progression-Free Survival, 3. Good health, Oncology, Clinical Trials, Phase III as Topic, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Quality of Life, 2730 Oncology, Female, Neoplasm Recurrence, Local, Ovaris - Tumors

File Description: application/pdf

Access URL: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.03107
https://pubmed.ncbi.nlm.nih.gov/32840418
https://hdl.handle.net/11351/6307
https://ascopubs.org/doi/full/10.1200/JCO.19.03107
https://christie.openrepository.com/handle/10541/623270
https://pubmed.ncbi.nlm.nih.gov/32840418/
https://doi.org/10.1200/JCO.19.03107
https://www.scilit.net/article/200c337ec06e2ef2ec67e311579e0eb0
https://moh-it.pure.elsevier.com/en/publications/patient-centered-outcomes-in-ariel3-a-phase-iii-randomized-placeb
https://hdl.handle.net/10807/167348
https://doi.org/10.1200/JCO.19.03107
https://discovery-pp.ucl.ac.uk/id/eprint/10109518/

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Authors: Jennifer B. Shah, Dana Pueschl, Bradley Wubbenhorst, Mengyao Fan, John Pluta, Kurt D’Andrea, Anna P. Hubert, Jake S. Shilan, Wenting Zhou, Adam A. Kraya, Alba Llop Guevara, Catherine Ruan, Violeta Serra, Judith Balmaña, Michael Feldman, Pat J. Morin, Anupma Nayak, Kara N. Maxwell, Susan M. Domchek, Katherine L. Nathanson

Contributors: Universitat Autònoma de Barcelona, Institut Català de la Salut, [Shah JB, Pueschl D, Wubbenhorst B, Fan M, Pluta J, D'Andrea K] Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. [Llop Guevara A, Serra V] Experimental Therapeutics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Balmaña J] Hereditary Cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: Nat Commun
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Nature Communications, Vol 13, Iss 1, Pp 1-19 (2022)

Subject Terms: 0301 basic medicine, Science, Mama - Càncer - Recaiguda, Loss of Heterozygosity, Breast Neoplasms, Article, 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, Breast cancer, Ovarian cancer, Cancer genomics, Humans, Cancer genetics, Ovaris - Càncer - Recaiguda, Germ-Line Mutation, Proportional Hazards Models, BRCA2 Protein, Ovarian Neoplasms, FENÓMENOS Y PROCESOS::fenómenos genéticos::variación genética::mutación, 0303 health sciences, BRCA1 Protein, RNA sequencing, 3. Good health, Anomalies cromosòmiques, PHENOMENA AND PROCESSES::Genetic Phenomena::Genetic Variation::Mutation, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Mutation, Female, DISEASES::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/36344544
https://hdl.handle.net/11351/8553
https://doaj.org/article/86e2b8acb27543e9aad8ac4d1b5b8463

A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma

Authors: Martin van den Bent, Analia Azaro, Filip De Vos, Juan Sepulveda, W. K. Alfred Yung, Patrick Y. Wen, Andrew B. Lassman, Markus Joerger, Ghazaleh Tabatabai, Jordi Rodon, Ralph Tiedt, Sylvia Zhao, Tiina Kirsilae, Yi Cheng, Sergio Vicente, O. Alejandro Balbin, Hefei Zhang, Wolfgang Wick

Contributors: Institut Català de la Salut, [van den Bent M] Erasmus University Medical Center (MC) Cancer Institute, Rotterdam, The Netherlands. [Azaro A] Unitat d’Investigació de Teràpia Molecular, Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [De Vos F] University Medical Center Utrecht, Utrecht, The Netherlands. [Sepulveda J] Hospital Universitario, 12 de Octubre, Madrid, Spain. [Yung WKA] MD Anderson Cancer Center, Houston, TX, USA. [Wen PY] Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA, Vall d'Hebron Barcelona Hospital Campus, MS Medische Oncologie, Cancer

Source: J Neurooncol
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

Subject Terms: Adult, Male, 0301 basic medicine, Cancer Research, PTEN, Maximum Tolerated Dose, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, Morpholines, Clinical Neurology, Cervell - Càncer - Quimioteràpia, Aminopyridines, Glioblastoma multiforme, 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, Humans, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Germ Cell and Embryonal::Neuroectodermal Tumors::Neoplasms, Neuroepithelial::Glioma::Astrocytoma::Glioblastoma, Tissue Distribution, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de células germinales y embrionarias::tumores neuroectodérmicos::neoplasias neuroepiteliales::glioma::astrocitoma::glioblastoma, c-Met, Aged, Triazines, Brain Neoplasms, INC280, Imidazoles, PTEN Phosphohydrolase, Middle Aged, Proto-Oncogene Proteins c-met, Prognosis, 3. Good health, Capmatinib, Oncology, Neurology, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Benzamides, Buparlisib, Clinical Study, Female, Neoplasm Recurrence, Local, Glioblastoma, Follow-Up Studies

File Description: application/pdf; image/pdf

Access URL: https://link.springer.com/content/pdf/10.1007/s11060-019-03337-2.pdf
https://pubmed.ncbi.nlm.nih.gov/31776899
https://hdl.handle.net/11351/6452
https://hdl.handle.net/20.500.12530/61496
https://pure.eur.nl/en/publications/8caa0e33-efe4-43be-9854-c376a9b59dcb
https://doi.org/10.1007/s11060-019-03337-2
https://mdanderson.elsevierpure.com/en/publications/a-phase-ibii-open-label-multicenter-study-of-inc280-capmatinib-al
https://link.springer.com/content/pdf/10.1007/s11060-019-03337-2.pdf
http://dspace.library.uu.nl/handle/1874/389056
https://link.springer.com/article/10.1007/s11060-019-03337-2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938467
https://repub.eur.nl/pub/122397
https://dspace.library.uu.nl/handle/1874/389056

Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies

Authors: Vladimir Lazar, Nicolas Girard, Eric Raymond, Jean-François Martini, Susan Galbraith, Jacques Raynaud, Catherine Bresson, Benjamin Solomon, Shai Magidi, Hovav Nechushtan, Amir Onn, Raanan Berger, Haiquan Chen, Amal Al-Omari, Sadakatsu Ikeda, Ulrik Lassen, Marina Sekacheva, Enriqueta Felip, Josep Tabernero, Gerald Batist, Alan Spatz, C.S. Pramesh, Philippe Girard, Jean-Yves Blay, Thierry Philip, Ioana Berindan-Neagoe, Angel Porgador, Eitan Rubin, Razelle Kurzrock, Richard L. Schilsky

Contributors: Institut Català de la Salut, [Lazar V, Raynaud J] Worldwide Innovative Network—WIN Consortium, Villejuif, France. [Girard N] Institut Curie, Paris, France. Institut du Thorax Curie—Institut Montsouris, Paris, France. [Raymond E] Groupe Hospitalier Saint-Joseph, Paris, France. [Martini JF] Pfizer Inc, San Diego, CA. [Galbraith S] AstraZeneca Plc, Cambridge, United Kingdom. [Felip E, Tabernero J] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: JCO Precis Oncol
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Lazar, V, Girard, N, Raymond, E, Martini, J, Galbraith, S, Raynaud, J, Bresson, C, Solomon, B, Magidi, S, Nechushtan, H, Onn, A, Berger, R, Chen, H, Al-omari, A, Ikeda, S, Lassen, U, Sekacheva, M, Felip, E, Tabernero, J, Batist, G, Spatz, A, Pramesh, C S, Girard, P, Blay, J, Philip, T, Berindan-neagoe, I, Porgador, A, Rubin, E, Kurzrock, R & Schilsky, R L 2022, ' Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies ', JCO Precision Oncology, no. 6, e2200072 . https://doi.org/10.1200/PO.22.00072

Subject Terms: Lung Neoplasms, FENÓMENOS Y PROCESOS::fenómenos genéticos::expresión génica::transcripción genética::fenómenos genéticos::transcriptoma, PHENOMENA AND PROCESSES::Genetic Phenomena::Gene Expression::Transcription, Genetic::Genetic Phenomena::Transcriptome, DISEASES::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas, Small Cell Lung Carcinoma, B7-H1 Antigen, Transcriptomes, 3. Good health, 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Pulmons - Càncer - Recaiguda, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Original Reports, Humans, CTLA-4 Antigen, Prospective Studies, Transcriptome, Pulmons - Càncer - Tractament, Lung, Retrospective Studies

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/36108261
https://hdl.handle.net/11351/8345
https://curis.ku.dk/ws/files/346601283/Transc.pdf

Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer

Authors: Rugo, Hope S., Tolaney, Sara M., Loirat, Delphine, Punie, Kevin, Bardia, Aditya, Hurvitz, Sara A., O'Shaughnessy, Joyce, Cortes, Javier, Dieras, Veronique, Carey, Lisa A., Gianni, Luca, Piccart, Martine J., Loibl, Sibylle, Goldenberg, David M., Hong, Quan, Olivo, Martin, Itri, Loretta M., Kalinsky, Kevin

Contributors: Institut Català de la Salut, [Rugo HS] Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. [Tolaney SM] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. [Loirat D] Department of Medical Oncology and D3i, Institut Curie, Paris, France. [Punie K] Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. [Bardia A] Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. [Hurvitz SA] Medical Oncology, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. [Cortés J] International Breast Cancer Center (IBCC), Quiron Group, Madrid & Barcelona, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

Source: NPJ Breast Cancer
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
npj Breast Cancer, Vol 8, Iss 1, Pp 1-10 (2022)
npj Breast Cancer, vol 8, iss 1

Subject Terms: IRINOTECAN, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Clinical Trials and Supportive Activities, ALOPECIA, 4202 Epidemiology, Medicaments antineoplàstics - Ús terapèutic, CAPECITABINE, SCALP COOLING DEVICE, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama::neoplasias de mama triple negativos, Article, 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, 0302 clinical medicine, Metàstasi, Clinical Research, 3211 Oncology and carcinogenesis, Breast Cancer, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms::Triple Negative Breast Neoplasms, Genetics, CONJUGATE, RC254-282, Cancer, OLDER, Science & Technology, Other subheadings::Other subheadings::Other subheadings::/drug therapy, 3202 Clinical sciences, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Généralités, ANTHRACYCLINE, CHEMOTHERAPY, 3. Good health, Oncology, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos, GUIDELINE, Mama - Càncer - Tractament, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, ERIBULIN, Patient Safety, Life Sciences & Biomedicine, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents

File Description: application/pdf; 1 full-text file(s): application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/36038616
https://hdl.handle.net/11351/8358
https://doaj.org/article/d9b62774a9d24a4da2cdc08d0bf5a33c
https://escholarship.org/content/qt7d91k2vh/qt7d91k2vh.pdf
https://escholarship.org/uc/item/7d91k2vh

Gene signatures in patients with early breast cancer and relapse despite pathologic complete response

Authors: Simona Bruzas, Oleg Gluz, Nadia Harbeck, Peter Schmid, Javier Cortés, Jens Blohmer, Christine Seiberling, Ouafaa Chiari, Hakima Harrach, Beyhan Ataseven, Satyendra Shenoy, Mark H. Dyson, Eugen Traut, Ingo Theuerkauf, Daniel Gebauer, Sherko Kuemmel, Mattea Reinisch

Contributors: Institut Català de la Salut, [Bruzas S] Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Essen, Germany. [Gluz O] West German Study Group, Moenchengladbach, Germany. Breast Center Niederrhein, Evangelical Hospital Bethesda, Moenchengladbach, Germany. [Harbeck N] Breast Center, Dept. OB&GYN and CCCLMU, University of Munich (LMU), Munich, Germany. [Schmid P] Barts Cancer Institute, Queen Mary University London, London, United Kingdom. [Cortés J] International Breast Cancer Centre (IBCC), Quiron Group, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain. Medica Scientia Innovation Research (MEDSIR), Ridgewood, NJ, USA. [Blohmer J] Klinik für Gynäkologie mit Brustzentrum, Charité-Universitätsmedizin Berlin, Berlin, Germany, Vall d'Hebron Barcelona Hospital Campus

Source: NPJ Breast Cancer
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
npj Breast Cancer, Vol 8, Iss 1, Pp 1-10 (2022)

Subject Terms: Other subheadings::Other subheadings::Other subheadings::/genetics, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Mama - Càncer - Recaiguda, Article, 3. Good health, 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, 0302 clinical medicine, Otros calificadores::Otros calificadores::Otros calificadores::/genética, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Mama - Càncer - Aspectes genètics, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama, RC254-282, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/35351903
https://hdl.handle.net/11351/8003
https://doaj.org/article/a3c6c0bda977445582cec1bd8ddfd149

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse

Authors: Gottfried von Keudell, Ariela Noy, Matthew J. Matasar, Philip Caron, Audrey Hamilton, M. Lia Palomba, Anas Younes, Paul A. Hamlin, Collette N. Owens, David J. Straus, David Sermer, Patrizia Mondello, Connie L Batlevi, Paola Ghione, Sabela Bobillo, Ahmet Dogan, Erel Joffe, Venkatraman E. Seshan, Anita Kumar, Alison J. Moskowitz, Andrew D. Zelenetz, Steven M. Horwitz

Contributors: Institut Català de la Salut, [Bobillo S] Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Joffe E, Sermer D, Mondello P, Ghione P, Caron PC] Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Vall d'Hebron Barcelona Hospital Campus

Source: Blood Cancer J
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-6 (2021)

Subject Terms: Adult, Male, Disease-free survival, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Cèl·lules B - Tumors - Tractament, Article, Central Nervous System Neoplasms, 03 medical and health sciences, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, 0302 clinical medicine, Càncer - Recaiguda, Recurrence, Risk Factors, DISEASES::Hemic and Lymphatic Diseases::Lymphatic Diseases::Lymphoproliferative Disorders::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse, Antineoplastic Combined Chemotherapy Protocols, Humans, Cyclophosphamide, RC254-282, Injections, Spinal, Aged, Retrospective Studies, Aged, 80 and over, Other subheadings::Other subheadings::Other subheadings::/drug therapy, B-cell lymphoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, 3. Good health, Sang - Malalties - Diagnòstic, Methotrexate, Doxorubicin, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Prednisone, Female, Lymphoma, Large B-Cell, Diffuse, Rituximab, B-cell lymphoma, Disease-free survival, Antineoplastic Combined Chemotherapy Protocols, Central Nervous System Neoplasms, Cyclophosphamide, Doxorubicin, Female, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades linfáticas::trastornos linfoproliferativos::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso, Follow-Up Studies

File Description: application/pdf

Access URL: https://www.nature.com/articles/s41408-021-00506-3.pdf
https://pubmed.ncbi.nlm.nih.gov/34135307
https://hdl.handle.net/11351/7097
https://doaj.org/article/da2cd3491fa94fc7a249c5f39c64ee22
https://www.nature.com/articles/s41408-021-00506-3.pdf
https://pubmed.ncbi.nlm.nih.gov/34135307/
https://www.nature.com/articles/s41408-021-00506-3
https://www.ncbi.nlm.nih.gov/pubmed/34135307
https://europepmc.org/article/MED/34135307
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209097
https://ddd.uab.cat/record/255712
https://hdl.handle.net/11570/3208431
https://doi.org/10.1038/s41408-021-00506-3
https://www.nature.com/articles/s41408-021-00506-3

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

Authors: Elizabeth M. Swisher, Tanya T. Kwan, Amit M. Oza, Anna V. Tinker, Isabelle Ray-Coquard, Ana Oaknin, Robert L. Coleman, Carol Aghajanian, Gottfried E. Konecny, David M. O’Malley, Alexandra Leary, Diane Provencher, Stephen Welch, Lee-may Chen, Andrea E. Wahner Hendrickson, Ling Ma, Prafull Ghatage, Rebecca S. Kristeleit, Oliver Dorigo, Ashan Musafer, Scott H. Kaufmann, Julia A. Elvin, Douglas I. Lin, Setsuko K. Chambers, Erin Dominy, Lan-Thanh Vo, Sandra Goble, Lara Maloney, Heidi Giordano, Thomas Harding, Alexander Dobrovic, Clare L. Scott, Kevin K. Lin, Iain A. McNeish

Contributors: Institut Català de la Salut, [Swisher EM] University of Washington, Seattle, WA, USA. [Kwan TT] Clovis Oncology, Inc., Boulder, CO, USA. [Oza AM] Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. [Tinker AV] BC Cancer—Vancouver, Vancouver, BC, Canada. [Ray-Coquard I] GINECO, Centre Léon Bérard and University Claude Bernard, Lyon, France. [Oaknin A] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Imperial College Healthcare NHS Trust- BRC Funding, Cancer Research UK, Ovarian Cancer Action

Source: Nat Commun
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Nature Communications, vol 12, iss 1

Subject Terms: Adult, Indoles, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Science, Antineoplastic Agents, Carcinoma, Ovarian Epithelial, Poly(ADP-ribose) Polymerase Inhibitors, Article, Promoter Regions, 03 medical and health sciences, Rare Diseases, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Recurrence, Local, 0302 clinical medicine, Genetic, Clinical Research, Ovarian Epithelial, Genetics, 80 and over, Humans, Promoter Regions, Genetic, Ovaris - Càncer - Recaiguda, Cancer, Aged, Platinum, Aged, 80 and over, BRCA2 Protein, Ovarian Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, BRCA1 Protein, Carcinoma, Ovaris - Càncer - Tractament, DNA Methylation, Middle Aged, Ovarian Cancer, 3. Good health, DNA-Binding Proteins, Good Health and Well Being, Neoplasm Recurrence, Local, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas, ENFERMEDADES::neoplasias::procesos neoplásicos::recurrencia neoplásica local, Female, DISEASES::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms, Neoplasm Recurrence, Local

File Description: application/pdf

Access URL: https://www.nature.com/articles/s41467-021-22582-6.pdf
https://pubmed.ncbi.nlm.nih.gov/33941784
https://hdl.handle.net/11351/6853
https://doaj.org/article/4c0bb318d2464bacb5fcd01f6ceefda3
https://www.nature.com/articles/s41467-021-22582-6.pdf
https://minerva-access.unimelb.edu.au/bitstream/handle/11343/278177/PMC8093258.pdf
http://ui.adsabs.harvard.edu/abs/2021NatCo..12.2487S/abstract
http://ahro.austin.org.au/austinjspui/handle/1/26424
https://europepmc.org/article/MED/33941784
https://ahro.austin.org.au/austinjspui/handle/1/26424
http://hdl.handle.net/10044/1/88649
https://escholarship.org/content/qt64s245z6/qt64s245z6.pdf
https://escholarship.org/uc/item/64s245z6